Malvern pharmaceutical company ordered to pay more than $1.5 billion after admitting it mislead doctors about a powerful opioid

  • 📰 PhillyInquirer
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

Endo-Guilty-Plea-Marketing-Opana-Opioid Notizia

Italia Ultime Notizie,Italia Notizie

Endo says it will actually pay far less than the ordered payouts, which make up the second-highest financial penalty ever brought against a pharmaceutical company.

Malvern pharmaceutical company ordered to pay more than $1.5 billion after admitting it mislead doctors about a powerful opioid

The company has also paid $450 million into trusts funding state and local efforts to combat the opioid crisis, the spokesperson said, noting this covers the company’s criminal forfeiture payment. Federal officials said that while EHSI’s “corporate affiliates emerged from bankruptcy” last month, EHSI itself will “cease to operate in its current form and not emerge from bankruptcy.”concerns had been raised for years about oxymorphone, which is three times more powerful than morphine

Endo, which is headquartered in Ireland but operates from Malvern, later pulled the drug from the market.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 81. in İT
 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Italia Ultime Notizie, Italia Notizie